Keating Laurie (CIK 0001620743)

Latest company ownership

IMRX - Immuneering Corp
Role: Director
Shares held
33,350
Last filed at
Jun 13, 2024
Confidence Score
50.0
2025Q4
Confidence Score History
2021Q3 2025Q4
PEPG - PepGen Inc.
Role: Director
Shares held
13,000
Last filed at
Jun 21, 2024
Confidence Score
50.0
2025Q4
Confidence Score History
2022Q2 2025Q4
ALNY - ALNYLAM PHARMACEUTICALS, INC.
Role: EVP, Chief Legal Officer
Shares held
12,258
Last filed at
Feb 12, 2020
Confidence Score
50.0
2025Q4
Confidence Score History
2017Q2 2025Q4

Recent buy/sell transactions

Exec date Filing date Company Role Signal Confidence Shares % of shares Under plan? Amount (USD)
May 6, 2022 Jan 19, 2023 PepGen Inc. Director Buy 91.3 +4,166 100.00% ✗ $50K
May 16, 2022 May 17, 2022 Immuneering Corp Director Buy 91.3 +7,000 100.00% ✗ $35K
Aug 5, 2021 Aug 9, 2021 ALNYLAM PHARMACEUTICALS, INC. EVP, Chief Legal Officer Sell 5.0 -10,000 -64.24% ✓ $1.9M
Aug 3, 2021 Aug 4, 2021 Immuneering Corp Director Buy 95.0 +7,000 100.00% ✗ $105K
Jul 12, 2021 Jul 14, 2021 ALNYLAM PHARMACEUTICALS, INC. EVP, Chief Legal Officer Sell 5.0 -6,812 -55.03% ✓ $1.2M
Jun 9, 2021 Jun 11, 2021 ALNYLAM PHARMACEUTICALS, INC. EVP, Chief Legal Officer Sell 12.5 -1,734 -23.75% ✓ $267K
Apr 19, 2021 Apr 21, 2021 ALNYLAM PHARMACEUTICALS, INC. EVP, Chief Legal Officer Sell 97.5 +2,429 49.87% ✗ $275.4K
Feb 11, 2021 Feb 16, 2021 ALNYLAM PHARMACEUTICALS, INC. EVP, Chief Legal Officer Sell 97.5 +2,203 82.57% ✗ $306K
Jan 13, 2021 Jan 15, 2021 ALNYLAM PHARMACEUTICALS, INC. EVP, Chief Legal Officer Sell 5.0 -9,027 -77.19% ✓ $1.5M
Jan 11, 2021 Jan 13, 2021 ALNYLAM PHARMACEUTICALS, INC. EVP, Chief Legal Officer Sell 5.0 -15,699 -60.77% ✓ $2.5M
Jul 13, 2020 Jul 14, 2020 ALNYLAM PHARMACEUTICALS, INC. EVP, Chief Legal Officer Sell 3.8 -47,250 -93.24% ✓ $7.6M
Apr 20, 2020 Apr 22, 2020 ALNYLAM PHARMACEUTICALS, INC. EVP, Chief Legal Officer Sell 5.0 -10,000 -40.12% ✓ $1.4M
Apr 7, 2020 Apr 9, 2020 ALNYLAM PHARMACEUTICALS, INC. EVP, Chief Legal Officer Sell 95.0 +2,234 17.60% ✗ $202.5K
Feb 10, 2020 Feb 12, 2020 ALNYLAM PHARMACEUTICALS, INC. EVP, Chief Legal Officer Sell 5.0 -10,000 -44.07% ✓ $1.3M
Jan 29, 2020 Jan 31, 2020 ALNYLAM PHARMACEUTICALS, INC. EVP, Chief Legal Officer Sell 7.5 -6,337 -41.24% ✓ $754.1K
Jan 27, 2020 Jan 29, 2020 ALNYLAM PHARMACEUTICALS, INC. EVP, Chief Legal Officer Sell 5.0 -41,037 -81.97% ✓ $4.8M
Aug 13, 2018 Aug 14, 2018 ALNYLAM PHARMACEUTICALS, INC. SVP, GC & Secretary Sell 90.0 +790 5.34% ✗ $55K
Jun 20, 2018 Jun 22, 2018 ALNYLAM PHARMACEUTICALS, INC. SVP, GC & Secretary Sell 28.8 -1,532 -9.39% ✓ $164.2K
Mar 20, 2018 Mar 22, 2018 ALNYLAM PHARMACEUTICALS, INC. SVP, GC & Secretary Sell 28.8 -1,562 -9.57% ✓ $234K
Mar 12, 2018 Mar 14, 2018 ALNYLAM PHARMACEUTICALS, INC. SVP, GC & Secretary Sell 5.0 -20,000 -40.60% ✓ $2.9M
Dec 20, 2017 Dec 21, 2017 ALNYLAM PHARMACEUTICALS, INC. SVP, GC & Secretary Sell 7.5 -6,249 -34.71% ✓ $757.4K
Dec 1, 2017 Dec 5, 2017 ALNYLAM PHARMACEUTICALS, INC. SVP, GC and Secretary Sell 5.0 -30,000 -71.84% ✓ $4.1M
May 30, 2017 May 31, 2017 ALNYLAM PHARMACEUTICALS, INC. SVP, GC and Secretary Buy 97.5 +11,500 5555.56% ✗ $751.5K